Nov 24 (Reuters) - Sigma Pharmaceuticals Ltd (SIP) - Sigma partnership with Fred It Group-sip.ax "Remain on track to deliver our previously upgraded guidance of underlying ebit growth of 10% for current fy and at least 5% for fy2018"
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status